tiprankstipranks
GlaxoSmithKline Updates Share Capital and Voting Rights
Company Announcements

GlaxoSmithKline Updates Share Capital and Voting Rights

GlaxoSmithKline (GSK) has released an update.

Don't Miss our Black Friday Offers:

GlaxoSmithKline (GSK) has announced that its issued share capital as of October 31, 2024, consists of over 4.3 billion ordinary shares, with a total of approximately 4.1 billion voting rights available. This information is crucial for shareholders calculating their interest in the company as per regulatory guidelines.

For further insights into GSK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyGSK, Zhifei revise, extend strategic vaccine collaboration in China
TheFlyGSK price target lowered to 1,600 GBp from 1,820 GBp at Berenberg
TheFlyGSK announces EC approved single-vial presentation of Menveo
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App